Olusiji A. Akinrinmade

Bellville, WC, South Africa

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Quiescent OXPHOS-high triple-negative breast cancer cells that persist after chemotherapy depend on BCL-XL for survival.

Quiescent OXPHOS-high triple-negative breast cancer cells that persist after chemotherapy depend on BCL-XL for survival.

Journal: bioRxiv : the preprint server for biology
Published: September 05, 2025

Quiescent OXPHOS-High Triple-Negative Breast Cancer Cells That Persist After Chemotherapy Depend on BCL-XL for Survival.

Quiescent OXPHOS-High Triple-Negative Breast Cancer Cells That Persist After Chemotherapy Depend on BCL-XL for Survival.

Journal: Cells
Published: August 21, 2025

The Therapeutic Potential of Photoimmunotherapy as a Safe, Effective and Non-Toxic Treatment Option for Superficial Triple Negative Breast Cancer.

The Therapeutic Potential of Photoimmunotherapy as a Safe, Effective and Non-Toxic Treatment Option for Superficial Triple Negative Breast Cancer.

Journal: Cancer medicine
Published: May 22, 2025

Anti-CD64(scFv)-SNAP-Auristatin F: An in vitro proof of concept study for a recombinant antibody conjugate targeting CD64+ acute monocytic leukemia.

Anti-CD64(scFv)-SNAP-Auristatin F: An in vitro proof of concept study for a recombinant antibody conjugate targeting CD64+ acute monocytic leukemia.

Journal: European journal of medicinal chemistry
Published: November 29, 2024

Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy.

Technological advances in the use of viral and non-viral vectors for delivering genetic and non-genetic cargos for cancer therapy.

Journal: Drug delivery and translational research
Published: April 29, 2023

A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug conjugate.

A recombinant Der p 1-specific allergen-toxin demonstrates superior killing of allergen-reactive IgG+ hybridomas in comparison to its recombinant allergen-drug conjugate.

Journal: Immunotherapy advances
Published: May 09, 2022

Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review.

Synergistic effects of radiotherapy and targeted immunotherapy in improving tumor treatment efficacy: a review.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 18, 2022

Using the SNAP-Tag technology to easily measure and demonstrate apoptotic changes in cancer and blood cells with different dyes.

Using the SNAP-Tag technology to easily measure and demonstrate apoptotic changes in cancer and blood cells with different dyes.

Journal: PloS one
Published: April 17, 2020

Human Granzyme B Based Targeted Cytolytic Fusion Proteins.

Human Granzyme B Based Targeted Cytolytic Fusion Proteins.

Journal: Biomedicines
Published: May 11, 2018

Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells.

Updates in the Development of ImmunoRNases for the Selective Killing of Tumor Cells.

Journal: Biomedicines
Published: February 08, 2018

CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.

CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases.

Journal: Biomedicines
Published: August 04, 2017

Human MAP Tau Based Targeted Cytolytic Fusion Proteins.

Human MAP Tau Based Targeted Cytolytic Fusion Proteins.

Journal: Biomedicines
Published: April 21, 2017
Showing 1-12 of 13

Last Updated: 09/26/2026